# ROCK inhibition in models of neurodegeneration and its potential for clinical translation

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/rock-inhibition-in-models-of-neurodegeneration-and-its-potential-for-clinical/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jan Christoph Koch,Lars Tatenhorst,Anna‐Elisa Roser,Kim‐Ann Saal,Lars Tönges,Paul Lingor |
| Citations | 247 |
| DOI | 10.1016/j.pharmthera.2018.03.008 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.sciencedirect.com/science/article/pii/S0163725818300561/pdf |
| OpenAlex ID | https://openalex.org/W2795818410 |
| PMID | 29621594 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Paul Lingor](https://scholariq.org/researchers/paul-lingor/)

## Paper journal

- [Pharmacology & Therapeutics](https://scholariq.org/journals/pharmacology-and-therapeutics/)

## Paper primary topic

- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)

## Paper topics

- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Protein Kinase Regulation and GTPase Signaling](https://scholariq.org/topics/protein-kinase-regulation-and-gtpase-signaling/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.